|
Liquid Tissue®-SRM AssaysExpression Pathology is advancing personalized medicine with assays that measure cancer signaling networks—at the functional protein level—in FFPE tissue. The assays can be multiplexed to simultaneously measure several different proteins. This may help to advance development of targeted therapies and to improve patient stratification. We offer a broad menu of multiplexed assays for major cancer signaling networks including EGFR, IGF-1R, cMET, HER2, HER3, cSRC, as well as many others. Contact us for the most updated lists and with custom requests. 
Multiplexed assays simultaneously measure a large number of different protein markers. (View larger image) |
custsvc@expressionpathology.com 